## Abstract ## BACKGROUND To the authors' knowledge, little is known to date regarding the prognostic relevance of measuring serum levels of vascular endothelial growth factor (VEGF), a potent stimulator of angiogenesis, in patients with colon carcinoma who undergo surgery. ## METHODS Preoperati
Decreased serum vascular endothelial growth factor-D levels in metastatic patients with differentiated thyroid carcinoma
โ Scribed by Roberto Nersita; Antonio Matrone; Michele Klain; Francesco Scavuzzo; Gabriella Vitolo; Ciro Abbondanza; Maria V. Carlino; Veronica Giacco; Giovanni Amato; Carlo Carella
- Book ID
- 108705040
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 100 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0300-0664
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
I read with interest the article by Kettritz et al. 1 regarding the accuracy of stereotactic 11-gauge vacuum-assisted breast biopsy (VAB) for diagnosing breast cancer in nonpalpable breast lesions. Of the 2893 VAB procedures performed, 19 (0.7%) yielded findings that were not representative, whereas
## Background: Angiogenesis is essential for tumor growth and metastasis. vascular endothelial growth factor (vegf) is the most potent angiogenic factor identified to date. the authors investigated the correlation between the levels of serum vegf (s-vegf) in patients with nasopharyngeal carcinoma (